Nutra Pharma Corp (NPHC) Net Equity Issued and Repurchased (2010 - 2016)

Nutra Pharma has disclosed Net Equity Issued and Repurchased across 7 years of filings, most recently posting $55000.0 for Q1 2016.

• In Q1 2016, Net Equity Issued and Repurchased changed N/A year-over-year to $55000.0; the TTM figure through Dec 2016 stood at $55000.0 (down 84.53% YoY), while the FY2016 annual figure was $55000.0, down 93.01% from the prior year.
• Net Equity Issued and Repurchased came in at $55000.0 for Q1 2016 at Nutra Pharma, down from $103800.0 in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $270000.0 in Q3 2012 to a low of $55000.0 in Q1 2016.
• Average Net Equity Issued and Repurchased over 5 years is $144568.6, with a median of $103800.0 recorded in 2015.
• The largest YoY upside for Net Equity Issued and Repurchased was 135.5% in 2012 against a maximum downside of 87.31% in 2012.
• Over 5 years, Net Equity Issued and Repurchased stood at $176500.0 in 2012, then plunged by 46.18% to $95000.0 in 2013, then tumbled by 36.84% to $60000.0 in 2014, then surged by 73.0% to $103800.0 in 2015, then plunged by 47.01% to $55000.0 in 2016.
• Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $55000.0 in Q1 2016, $103800.0 in Q4 2015, and $251680.0 in Q3 2015.